FDA Adverse Event Injury Summary report: N

PERCLOSE PROGLIDE 6F SUTURE MEDIATED CLOSURE (SMC) SYSTEM

MDR report key: 2873982 · Received December 14, 2012

Report

Report Number
2024168-2012-07930
Event Type
Injury
Date Received
December 14, 2012
Date of Event
December 3, 2012
Report Date
December 4, 2012
Manufacturer
AV-TEMECULA-CT
Product Code
MGB
PMA / PMN Number
P960043
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THE DEVICE IS EXPECTED TO BE RETURNED FOR INVESTIGATION. IT HAS NOT YET BEEN RECEIVED. A FOLLOW UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL INFORMATION. THE OTHER THREE PROGLIDE DEVICES REFERENCED, ARE BEING FILED UNDER SEPARATE MEDWATCH MFR NUMBERS.

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: THE DEVICE WAS RETURNED FOR EVALUATION. THE REPORTED EVENT WAS CONFIRMED. ALSO, THE ANALYSIS REVEALED THAT A PORTION OF THE POSTERIOR FOOT POCKET WAS BROKEN OFF AND NOT RETURNED WITH THE DEVICE. THE LOCATION OF THE BROKEN POSTERIOR FOOT PORTION WAS NOT KNOWN. BASED ON VISUAL ANALYSIS OF THE RETURNED DEVICE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. A REVIEW OF THE LOT HISTORY RECORD REVEALED NO NON-CONFORMANCES THAT WOULD HAVE CONTRIBUTED TO THE REPORTED EVENT. BASED ON THE INFORMATION REVIEWED, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY.

Description of Event or Problem · 1

IT WAS REPORTED THAT CUFF MISSES OCCURRED DURING ATTEMPTED SUTURE PLACEMENT IN BOTH MODERATELY CALCIFIED COMMON FEMORAL ARTERIES USING THE PERCLOSE TECHNIQUE PRIOR TO AN ENDOVASCULAR ABDOMINAL AORTIC ANEURYSM (AAA) PROCEDURE. A SECOND PROGLIDE DEVICE WAS USED ON BOTH SIDES WITH THE SAME RESULTS. ANOTHER PROGLIDE DEVICE WAS USED ON EACH SIDE FOR SUCCESSFUL SUTURE PLACEMENT. THE AAA PROCEDURE WAS COMPLETED AND HEMOSTASIS WAS ACHIEVED WITH THE SUCCESSFULLY DEPLOYED PROGLIDE DEVICES. THERE WAS NO REPORTED ADVERSE PATIENT SEQUELA OR CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE OR THERAPY. IT WAS REPORTED THAT THE PHYSICIAN IS TRAINED IN THE USE OF THE PERCLOSE PROGLIDE DEVICE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PERCLOSE PROGLIDE 6F SUTURE MEDIATED CLOSURE (SMC) SYSTEM SUTURE MEDIATED CLOSURE MGB AV-TEMECULA-CT 20928J1

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention SHEATHS: 6F, IN EXCESS OF 14FHEPARIN